9 Advanced Solid Tumors Clinical Trials in Commack, NY (2026)

Q: How do I join a clinical trial in Commack?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you.

Recruiting Advanced Solid Tumors Studies in Commack

NCT05123482Recruiting

A Phase I/IIa Study of AZD8205 Given Alone or in Combination With Anticancer Drugs, in Participants With Advanced or Metastatic Solid Malignancies

This research study is studying a new compound, AZD8205, as a possible treatment for advanced or metastatic solid tumours alone or in combination with anti-cancer agents...

Commack, NYPHASE1460 participantsAstraZeneca

View Study Details

NCT05489211Recruiting

Study of Dato-Dxd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)

TROPION-PanTumor03 will investigate the safety, tolerability, and anti-tumour activity of Datopotamab Deruxtecan (Dato-DXd) as Monotherapy and in Combination with Anticancer Agents in Patients with Ad...

Commack, NYPHASE2454 participantsAstraZeneca

View Study Details

NCT06219941Recruiting

AZD0901 in Participants With Advanced Solid Tumours Expressing Claudin18.2

The purpose of this study is to assess the safety, tolerability, efficacy, pharmacokinetics (PK), and immunogenicity of AZD0901 as monotherapy and in combination with anti-cancer agents in participant...

Commack, NYPHASE2224 participantsAstraZeneca

View Study Details

NCT04165772Recruiting

Study of Induction PD-1 Blockade in Subjects With Locally Advanced Mismatch Repair Deficient Solid Tumors

The purpose of this study is to find out whether the study drug, TSR-042, followed by standard chemoradiotherapy (the chemotherapy drug capecitabine + radiation therapy) and standard surgery is an eff...

Commack, NYPHASE2212 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT01775072Recruiting

Genomic Profiling in Cancer Patients

The purpose of this study is to determine whether certain genes in cancer may be abnormal. When a gene is abnormal this is called a mutation. Most mutations in cancer cells are not inherited (passed d...

Commack, NY200 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT03808337Recruiting

Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease

This study is being done to determine if stereotactic body radiotherapy (SBRT) when delivered to all sites of disease in participants with 1-5 metastases will increase the length of time before partic...

Commack, NYPHASE2145 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07225088Recruiting

DESCANSO, a Mental Health Intervention for Depression, Insomnia, and Fatigue Symptoms in Latino People With Cancer

The purpose of this study is to improve ways of providing mental health support to Spanish-speaking Latino participants who have cancer and experience depression, insomnia, and fatigue. Investigators ...

Commack, NYNA125 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT05010031Recruiting

A Study of Reduced-dose Radiation in People With Metastatic Tumors With a Genetic Change

This study will test whether reduced-dose radiotherapy is an effective treatment for metastatic tumors with an ATM mutation. The researchers want to find the lowest dose of radiation that would still ...

Commack, NYPHASE245 participantsMemorial Sloan Kettering Cancer Center

View Study Details

NCT07638371Recruiting

FORTRAS: A Study of MSK-TCR5 in People With Solid Tumor Cancers

The purpose of this study is to test the safety of MSK-TCR5 in participants with advance solid tumor cancer that has a KRAS, HRAS, or NRAS G12D mutation....

Commack, NYPHASE116 participantsMemorial Sloan Kettering Cancer Center

View Study Details

About Advanced Solid Tumors Clinical Trials in Commack

Advanced solid tumors refer to cancers that have grown beyond the original site or spread to distant organs. Many clinical trials enroll patients with various types of advanced solid tumors to test novel therapies. These trials often investigate immunotherapy, targeted therapy, and combination approaches.

There are currently 9 advanced solid tumors clinical trials recruiting participants in Commack, NY. These studies are seeking a combined 1,881 participants. Research is being sponsored by AstraZeneca, Memorial Sloan Kettering Cancer Center. Clinical trial participation is free and participants receive study-related medical care at no cost.

Advanced Solid Tumors Clinical Trials in Commack — FAQ

Are there advanced solid tumors clinical trials in Commack?

Yes, there are 9 advanced solid tumors clinical trials currently recruiting in Commack, NY. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Commack?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Commack research site will contact you about next steps.

Are clinical trials in Commack free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Commack studies also compensate for your time and travel.

What advanced solid tumors treatments are being tested?

The 9 active trials in Commack are testing new therapies including novel drugs, biologics, and treatment approaches for advanced solid tumors.

Data updated July 21, 2026 from ClinicalTrials.gov